EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evaluation of AAV vectors with tissue-specific or ubiquitous promoters in a mouse model of mucopolysaccharidosis type IVA

Shaukat A Khan, Jose Victor Álvarez, F N U Nidhi, Eliana Benincore-Florez, Shunji Tomatsu

Molecular Therapy Methods & Clinical Development · 2025-06 · 33 (2) · 101447

DOI: 10.1016/j.omtm.2025.101447 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy Methods & Clinical Development, 2025-06. Verfasst von Shaukat A Khan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Research, Nemours Children's Health, Wilmington, DE 19803, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucopolysaccharidosis type IVA (MPS IVA) is caused by a deficiency of N-acetyl-galactosamine-6-sulfate sulfatase (GALNS), leading to the accumulation of keratan sulfate and chondroitin-6-sulfate and development of severe skeletal dysplasia. Enzyme replacement therapy and hematopoietic stem cell transplantation are current treatment options but have limited impact on bone lesions. In this study, we investigated adeno-associated virus (AAV)8 or AAV9 vectors with liver-specific thyroxine-binding globulin or liver-specific promoter-a modification of hAAT (LSPX), liver-muscle tandem (LMTP), liver-bone tandem (LBTP), and ubiquitous cytomegalovirus early enhancer/chicken β-actin (CAG) promoters in MPS IVA mice to compare therapeutic efficacy on biochemical markers and bone pathology. All vectors provided near- or supraphysiological levels of GALNS enzyme activity in plasma. Enzyme activities were also detected in various tissues, including bone. AAV9co-CAG, AAV9co-LMTP, and AAV9co-LBTP showed higher enzyme activities in the liver; however, AAV8co-CAG and AAV9co-LMTP have higher activities in most other tissues. All vectors normalized keratan sulfate levels in plasma, liver, and bone. Pathological analyses showed the reduction or complete absence of vacuolated cells in heart muscle and valves in all treated mice, while the AAV9co-LMTP vector most improved bone pathology. Overall, all studied vectors indicated a substantial improvement in biochemical parameters and pathology, and the AAV9co-LMTP vector demonstrated the best combined therapeutic efficacy.

Schlagwörter

Stichwörter der Autor:innen

AAVAAV8AAV9CAGERTGAGGALNSHSCTLBTPLMTPMPS IVATBGadeno-associated viruscytomegalovirus early enhancer/chicken β-actin promoterenzyme replacement therapy

Autor:innen und Institutionen

  • Department of Biomedical Research, Nemours Children's Health, Wilmington, DE 19803, USA.
  • Department of Pediatrics, Hospital Clínico Universitario de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), CIBERER, MetabERN, 15706 Santiago de Compostela, Spain.
  • Department of Biological Sciences, University of Delaware, Newark, DE 19716, USA.
  • Department of Pediatrics, Shimane University, Izumo 693-8501, Japan.
  • Department of Pediatrics, Graduate School of Medicine, Gifu University, Gifu 501-1193, Japan.
  • Department of Pediatrics, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Förderung

  • NICHD NIH HHS

Zitieren

APA

Khan, S. A., Álvarez, J. V., Nidhi, F. N. U., Benincore-Florez, E., & Tomatsu, S. (2025). Evaluation of AAV vectors with tissue-specific or ubiquitous promoters in a mouse model of mucopolysaccharidosis type IVA. Molecular Therapy Methods & Clinical Development, 33(2), 101447. https://doi.org/10.1016/j.omtm.2025.101447

Vancouver

Khan SA, Álvarez JV, Nidhi FNU, Benincore-Florez E, Tomatsu S. Evaluation of AAV vectors with tissue-specific or ubiquitous promoters in a mouse model of mucopolysaccharidosis type IVA. Molecular Therapy Methods & Clinical Development. 2025;33(2):101447. doi:10.1016/j.omtm.2025.101447

BibTeX
@article{Khan2025,
  author = {Khan, Shaukat A and Álvarez, Jose Victor and Nidhi, F N U and Benincore-Florez, Eliana and Tomatsu, Shunji},
  title = {Evaluation of AAV vectors with tissue-specific or ubiquitous promoters in a mouse model of mucopolysaccharidosis type IVA},
  journal = {Molecular Therapy Methods & Clinical Development},
  year = {2025},
  volume = {33},
  number = {2},
  pages = {101447},
  doi = {10.1016/j.omtm.2025.101447}
}
Kostenlos starten →